Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRDX5 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | CCDC142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | GRIP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | LRRC8C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | NDUFV1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | VASH2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | PRH1-PRR4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | CCDC154 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | TRADD | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | TSPAN19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |